Clinical Trial Update: Saxenda in Obesity Services (STRIVE Study) [Phase 4]

View source ↗

Summary

Phase 4 STRIVE trial evaluating Saxenda (liraglutide) in obesity services has completed, with results posted in 2024. The study covers obesity and diabetes mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Obesity

Drugs mentioned

• SAXENDA (liraglutide)

Snippet

Sponsor: University of Leicester | Conditions: Obesity, Weight Loss | Phase 4 | Status: COMPLETED | Results posted: 2024-08-13